CAS 109664-02-0: 1-hydroxy-2-(1-hydroxypropan-2-yl)-8,8-dimethyl-5,6,7,8-tetrahydrophenanthrene-3,4-dione

Neocryptotanshinone is a bioactive compound, which is a naturally occurring diterpene quinone derivative. This product is primarily sourced from the roots of Salvia miltiorrhiza, commonly known as Danshen, a plant extensively used in traditional Chinese medicine. It exhibits a complex mode of action, primarily involving the modulation of signaling pathways critical to cellular functions. Specifically, neocryptotanshinone has been observed to inhibit certain kinases and transcription factors, impacting cell cycle regulation and apoptosis. In terms of uses and applications, neocryptotanshinone has attracted significant interest for its potential therapeutic properties. It has been studied for its anti-cancer, anti-inflammatory, and anti-oxidative effects. Research indicates that it may interfere with tumor progression by inducing cell cycle arrest and promoting programmed cell death in cancerous cells. Additionally, its anti-inflammatory properties are of particular interest in the treatment of chronic inflammatory diseases. As a result, neocryptotanshinone holds promise as a candidate for further pharmaceutical development, with ongoing studies exploring its role in therapeutic interventions against various pathological conditions.

Neocryptotanshinone inhibits rabbit platelet aggregation induced by arachidonic acid.